Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 1B study to evaluate the safety, tolerability and preliminary efficacy of the Combination of Encorafenib, Binimetinib and Palbociclib in patients with BRAF- mutant metastatic melanoma (The CELEBRATE study)
Shackleton, Mark
(Primary Chief Investigator (PCI))
Hawkins, Cheryl-Ann
(Project Manager)
Medicine Alfred Hospital
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
5/05/21
→
31/12/24
View all
View less
Keywords
Metastatic Melanoma
Oncology
Clinical trial